TRANSCODE THERAPEUTICS, INC. (RNAZ) Return on equity
TRANSCODE THERAPEUTICS, INC. (RNAZ) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
No annual history for this metric yet
The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.
← Back to RNAZSource: SEC XBRL filings · For reference only · Not investment advice
More RNAZ financial trends
RNAZ RevenueRNAZ Net incomeRNAZ Net marginRNAZ Gross profitRNAZ Gross marginRNAZ Operating incomeRNAZ Operating marginRNAZ Operating cash flowRNAZ Free cash flowRNAZ Capital expendituresRNAZ Stock buybacksRNAZ Dividends paidRNAZ Total assetsRNAZ Total liabilitiesRNAZ Shareholders’ equityRNAZ overview →